[1] Ren W, Qi X, Yang Z, et al. Prevalence and risk factors of hepatocellular carcinoma in Budd-Chiari syndrome: a systematic review[J].Eur J Gastroenterol Hepatol,2013,25(7):830-841.
[2] Kew Mc,McKnJight A,Hodkinson J,et al.The role of membranous obstruction of the inferior vena cava in the etiology of hepatocellular carcinoma in Southern African blacks[J].Hepatology,1989,9(1):121-125.
[3] Darnis B, Rode A, Mohkam K, et al.Management of bleeding liver tumors [J].J Visc Surg,2014,151(5): 365-375.
[4] Brown K T, Do Rk, Gonen M, et al. Randomized trial of hepatic artery embolization for hepatocellular carcinoma using doxorubicin-eluting microspheres compared with embolization with microspheres alone[J].J Clin Oncol,2016,34(17):2046-2053.
[5] Yoshida H, Mamada Y, Taniai N, et al. Spontaneous ruptured hepatocellular carcinoma[J].Hepatol Res,2016,46(1):13-21.
[6] Zhang W, Huang Z, Che X.Emergency versus delayed hepatectomy following transarterial embolization in spontaneously ruptured hepatocellular carcinoma survivors: a systematic review and meta-analysis[J].World J Surg Oncol,2022,20(1):365.
[7] 刘烨磊,黄静,李张辉,等.肝癌破裂出血手术治疗进展[J].肝胆胰外科杂志,2022,34(2):117-120.
[8] Okamoto E,Suzuki F,Kuwata K,et al.Simuhaneous radical surgical treatment for membranous obstruction of the inferior vena cava and the coincidengt hepatocellular carcinoma—the first successful case[J].Jpn J Surg,1983,13(2):135-140.
[9] Wang Y D, Xue H Z, Zhang X,et al.Clinical and pathological features and surgical treatment of Budd-Chiari syndrome-associated hepatocellular carcinoma[J].Chin Med J (Engl),2013,126(19):3632-3638. |
